Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
28-week randomized open-label comparison of aripiprazole once-monthly versus paliperidone palmitate in adults with schizophrenia
2012-002785-12Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aripiprazole in schizophrenia (2 arms), sponsored by Lundbeck. Primary endpoint: Mean change from baseline in quality of life. Started Feb 2013; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2012-002785-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002785-12.